Why CureBay’s Acquisition Could Transform Healthcare Delivery in India

Hybrid healthcare startup CureBay has acquired the pharma distribution business of Saveo Healthtech, strengthening its supply chain capabilities as it moves toward becoming a full-stack healthcare provider in India. The financial details of the transaction were not disclosed.

The acquisition marks a strategic step in CureBay’s expansion, enabling the company to integrate medicine distribution with its existing healthcare services.

Expanding Pharma Distribution Network

As part of the deal, CureBay gains access to Saveo’s well-established pharmaceutical distribution infrastructure, which includes:

• A network serving over 10,000 retail pharmacies across southern India

• Distribution hubs in Bengaluru and Hyderabad

• Procurement and supply chain capabilities

• A technology-enabled ordering platform

This infrastructure will allow CureBay to enhance its medicine delivery efficiency and supply chain management.

Read more: Why CometChat’s $6.5M Funding Signals a Shift Toward AI-Driven Engagement

Strengthening Healthcare Delivery

CureBay plans to integrate Saveo’s distribution network with its own platform to improve:

• Fulfilment cycles

• Inventory visibility

• Availability of medicines in remote areas

By combining healthcare services with pharmaceutical distribution, the company aims to deliver a more seamless and reliable patient experience.

Building a Full-Stack Healthcare Model

Founded by Priyadarshi Mohapatra, CureBay operates a hybrid model that blends physical healthcare centres with digital services.

The company currently:

• Runs over 190 eClinics

• Serves 15,000 villages across India

• Has provided services to more than one million patients

Its offerings include:

• Teleconsultation

• Diagnostic services

• Pharmacy access

• Referral services

With the addition of pharma distribution, CureBay is moving closer to becoming a fully integrated healthcare platform, covering the entire patient journey.

Integration Already Underway

The company has already begun integrating Saveo’s operations into its ecosystem, with combined services being deployed in select markets.

This early integration indicates CureBay’s focus on rapid execution and operational synergy, ensuring that the acquisition delivers immediate value.

Backed by Strong Investor Support

CureBay’s expansion strategy is supported by significant investor backing.

In May 2025, the company raised $21 million in a Series B funding round, led by Bertelsmann India Investments, at a valuation of around $75 million.

The latest acquisition aligns with its broader vision of scaling healthcare access, particularly in underserved and rural regions.

The Bigger Picture: Healthcare + Supply Chain Integration

CureBay’s move reflects a larger trend in India’s healthcare sector, where companies are increasingly adopting integrated, end-to-end models.

By combining:

• Healthcare services

• Digital platforms

• Pharmaceutical distribution

companies can improve efficiency, reduce costs, and enhance patient outcomes.

What Lies Ahead

With this acquisition, CureBay is better positioned to:

• Expand its reach across rural and semi-urban markets

• Improve medicine availability and delivery timelines

• Strengthen its competitive position in the healthtech space

As the company continues to scale, its focus on technology-driven healthcare and supply chain integration could play a key role in shaping the future of accessible healthcare in India.

Final Take

CureBay’s acquisition of Saveo Healthtech’s pharma distribution business is more than just a strategic expansion — it is a step toward building a comprehensive healthcare ecosystem.

By integrating medical services with supply chain capabilities, the company is addressing one of the biggest challenges in healthcare: ensuring timely access to quality treatment and medicines.